发明名称 |
Controlled release hydrocodone formulations |
摘要 |
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material. |
申请公布号 |
US9205056(B2) |
申请公布日期 |
2015.12.08 |
申请号 |
US201514728023 |
申请日期 |
2015.06.02 |
申请人 |
Purdue Pharma L.P. |
发明人 |
Oshlack Benjamin;Huang Hua-Pin;Masselink John K.;Tonelli Alfred |
分类号 |
A61K9/00;A61K9/14;A61K9/20;A61K31/194;A61K31/46;A61K31/485 |
主分类号 |
A61K9/00 |
代理机构 |
Davidson, Davidson & Kappel, LLC |
代理人 |
Davidson, Davidson & Kappel, LLC |
主权项 |
1. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising a matrix comprising a bitartrate salt of hydrocodone and microcrystalline cellulose, the dosage form, after administration to a human subject, providing a C24/Cmax hydrocodone ratio of from about 0.55 to about 1.0, wherein
the dosage form is a tablet, the amount of hydrocodone in the dosage form is from about 0.5 mg to about 1250 mg, and the bitartrate salt of hydrocodone is the only active agent in the dosage form. |
地址 |
Stamford CT US |